CARDIOPHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 13966273
Bregnevej 39, 2820 Gentofte
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 811.19 | 3 438.35 | 437.95 | 2 618.26 | 2 651.30 |
| Gross profit | 811.19 | 3 438.35 | 437.95 | 2 618.26 | 2 651.30 |
| Costs of management | - 107.15 | - 252.91 | -90.13 | -61.89 | -20.64 |
| EBIT | 704.05 | 3 185.44 | 347.83 | 2 556.37 | 2 630.66 |
| Other financial income | 3 672.63 | 45.28 | 414.50 | 657.57 | 90.79 |
| Other financial expenses | - 156.34 | - 581.26 | -2.87 | - 355.14 | - 257.80 |
| Reduction non-current investment assets | - 709.34 | ||||
| Income from other inv. held as non-curr. assets | 59.69 | 253.04 | 262.77 | 51.85 | 214.08 |
| Pre-tax profit | 4 280.02 | 2 902.51 | 1 022.22 | 2 910.65 | 1 968.39 |
| Income taxes | -1.44 | -1.82 | -3.58 | -0.34 | |
| Net earnings | 4 278.59 | 2 900.69 | 1 018.64 | 2 910.30 | 1 968.39 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Participating interests | 2 147.48 | 2 147.48 | 2 147.48 | 2 147.48 | 2 147.48 |
| Investments total | 2 147.48 | 2 147.48 | 2 147.48 | 2 147.48 | 2 147.48 |
| Non-current loans receivable | 12 778.21 | 17 426.21 | 18 385.67 | 19 266.61 | 18 828.42 |
| Non-current other receivables | 1 888.23 | 1 739.39 | 1 785.21 | 1 809.15 | 1 018.48 |
| Long term receivables total | 14 666.44 | 19 165.60 | 20 170.88 | 21 075.76 | 19 846.90 |
| Inventories total | |||||
| Current other receivables | 0.01 | ||||
| Current deferred tax assets | 60.41 | 68.61 | 66.21 | 62.32 | 4.29 |
| Short term receivables total | 60.41 | 68.61 | 66.21 | 62.32 | 4.30 |
| Other current investments | 12 582.17 | 5 415.34 | 3 577.01 | 3 757.00 | 4 797.85 |
| Cash and bank deposits | 668.05 | 1 276.32 | 2 160.42 | 1 260.45 | 1 736.70 |
| Cash and cash equivalents | 13 250.22 | 6 691.66 | 5 737.43 | 5 017.45 | 6 534.54 |
| Balance sheet total (assets) | 30 124.56 | 28 073.35 | 28 121.99 | 28 303.02 | 28 533.23 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Shares repurchased | 5 000.00 | 1 000.00 | 700.00 | 3 675.00 | |
| Other reserves | -1 950.00 | ||||
| Retained earnings | 20 677.08 | 23 955.66 | 26 156.35 | 23 499.99 | 26 410.30 |
| Profit of the financial year | 4 278.59 | 2 900.69 | 1 018.64 | 2 910.30 | 1 968.39 |
| Shareholders equity total | 30 080.66 | 27 981.35 | 27 999.99 | 28 260.29 | 28 503.68 |
| Non-current liabilities total | |||||
| Current owed to participating | 1.70 | 50.00 | 0.72 | 2.54 | |
| Other non-interest bearing current liabilities | 42.20 | 42.00 | 122.00 | 42.00 | 27.00 |
| Current liabilities total | 43.89 | 92.00 | 122.00 | 42.72 | 29.54 |
| Balance sheet total (liabilities) | 30 124.56 | 28 073.35 | 28 121.99 | 28 303.02 | 28 533.23 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.